Vulvovaginal atrophy. Postmenopausal atrophic vaginitis
Conditions
Interventions
Intervention group: Use Vaginal Cream (Traditional Iranian Medicine Product) Contains Chicken Oil and Honey Wax, One applicator every other night for 2 weeks followed by one applicator two nights a we
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Having a patient's consent to participate in the project Ability to fill out forms and questionnaires alone or with the help of a researcher 18 years or older Married Menopause History of breast cancer Hormonal treatment history Having subjective symptoms of vulvovaginal atrophy (itching, burning, dryness, dyspareunia) with a minimal sum score of 3
Exclusion criteria
Exclusion criteria: Having multiple sex partners Acute psychiatric illness and antidepressant use during the last month Other cancers at the same time as breast cancer Incomplete chemotherapy and radiotherapy Use of lubricant or vaginal moisturizer and other vaginal medications during the last month Not having a negative Pap smear over the last year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective Symptom Score of Vulvovaginal Atrophy Based on Vulvovaginal Subjective Symptom Score Form from 3 to 16. Timepoint: Evaluation of subjective symptoms of vulvovaginal atrophy at baseline (before intervention), 2 and 4 weeks after the intervention beginning, 2 and 4 weeks after the intervention completion. Method of measurement: Vulvovaginal Subjective Symptom Score Form.;Vulvovaginal Dryness Score Based on Vulvovaginal Subjective Symptom Score Form from 1 to 4. Timepoint: Evaluation of vulvovaginal dryness at baseline (before intervention), 2 and 4 weeks after the intervention beginning, 2 and 4 weeks after the intervention completion. Method of measurement: Vulvovaginal Subjective Symptom Score Form.;Vulvovaginal Itching Score Based on Vulvovaginal Subjective Symptom Score Form from 1 to 4. Timepoint: Evaluation of vulvovaginal Itching at baseline (before intervention), 2 and 4 weeks after the intervention beginning, 2 and 4 weeks after the intervention completion. Method of measurement: Vulvovaginal Subjective Symptom Score Form.;Vulvovaginal burning Score Based on Vulvovaginal Subjective Symptom Score Form from 1 to 4. Timepoint: Evaluation of vulvovaginal burning at baseline (before intervention), 2 and 4 weeks after the intervention beginning, 2 and 4 weeks after the intervention completion. Method of measurement: Vulvovaginal Subjective Symptom Score Form.;Dyspareunia Score Based on Vulvovaginal Subjective Symptom Score Form from 1 to 4. Timepoint: Evaluation of dyspareunia at baseline (before intervention), 2 and 4 weeks after the intervention beginning, 2 and 4 weeks after the intervention completion. Method of measurement: Vulvovaginal Subjective Symptom Score Form. | — |
Secondary
| Measure | Time frame |
|---|---|
| Female Sexual Function Index Score. Timepoint: At the beginning of the study (before intervention) and 4 weeks after the intervention (Intervention completion). Method of measurement: Female Sexual Function Index Questionnaire.;Sexual desire score. Timepoint: At the beginning of the study (before intervention) and 4 weeks after the intervention (Intervention completion). Method of measurement: Female Sexual Function Index Questionnaire.;Sexual arousal score. Timepoint: At the beginning of the study (before intervention) and 4 weeks after the intervention (Intervention completion). Method of measurement: Female Sexual Function Index Questionnaire.;Vaginal lubrication score. Timepoint: At the beginning of the study (before intervention) and 4 weeks after the intervention (Intervention completion). Method of measurement: Female Sexual Function Index Questionnaire.;Orgasm score. Timepoint: At the beginning of the study (before intervention) and 4 weeks after the intervention (Intervention completion). Method of measurement: Female Sexual Function Index Questionnaire.;Sexual satisfaction score. Timepoint: At the beginning of the study (before intervention) and 4 weeks after the intervention (Intervention completion). Method of measurement: Female Sexual Function Index Questionnaire.;Sexual pain score. Timepoint: At the beginning of the study (before intervention) and 4 weeks after the intervention (Intervention completion). Method of measurement: Female Sexual Function Index Questionnaire.;Satisfaction of treatment. Timepoint: After the Intervention completion. Method of measurement: Asking the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Radmanesh
Shahid Beheshti University of Medical Sciences
Outcome results
None listed